| 发明名称 |
PHARMACEUTICAL FORMULATION CONTAINING ATORVASTATIN CALCIUM |
| 摘要 |
<p>Disclosed invention relates to pharmaceutical formulation containing atorvastatin calcium (hemi calcium salt of (R-(R*,R*))-2-(4-fluorophenyl)-Beta, Delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4((enylamino)carbonyl)-1H-pyrol-1-heptanoic acid). The invention is solving the problem how to assure a therapeutical equivalence of pharmaceutical formulations containing atorvastatin calcium without dependence on what form of atorvastatin calcium (crystallinic, amorphous, mixture of both) is used for their preparation</p> |
| 申请公布号 |
SI20848(A) |
申请公布日期 |
2002.10.31 |
| 申请号 |
SI20010000069 |
申请日期 |
2001.03.14 |
| 申请人 |
LEK, TOVARNA FARMACEVTSKIH IN KEMIJSKIH IZDELKOV, D.D. |
发明人 |
KERC JANEZ;SALOBIR MATEJA;BAVEC SASA |
| 分类号 |
C07D207/16;A61K9/08;A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K31/40;A61K47/02;A61K47/12;A61K47/18;A61P3/06;A61P43/00;(IPC1-7):A61K9/20;A61K47/00;A61P7/00 |
主分类号 |
C07D207/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
